The effect of epidermal growth factor receptor mutation on adjuvant chemotherapy with tegafur/uracil for patients with completely resected, non-lymph node metastatic non-small cell lung cancer (> 2 cm): a multicenter, retrospective, observational study as exploratory analysis of the CSPOR-LC03 study.
Tomohiro MiyoshiKeiju AokageShun-Ichi WatanabeHiroyuki ItoNoriaki SakakuraMingyon MunMotohiro YamashitaYasuhisa OhdeTadashi AokiWataru NishioMasataka TaguriMasahiro TsuboiPublished in: Japanese journal of clinical oncology (2024)
In pathologic stage I (>2 cm) lung adenocarcinomas with EGFR mutation, the survival benefit of adjuvant UFT was not observed.